Etem İbrahim PİŞKİN, Nilgün E. ATAY

Akut bronşiyolit tedavisinde yeni yaklaşımlar

Akut viral bronşiyolit iki yaş altı çocuklarda en sık görülen alt solunum yolu infeksiyonu olup, altı aydan küçük çocuklarda hastaneye yatırılma nedenlerinin başında gelmektedir. Bu yaygın hastalığın tedavisinde dünyaca kabul edilen en iyi yaklaşım hava yolu bakımı, yeterli hidrasyonun sağlanması ve oksijenasyonla sınırlıdır. Tedavide bronkodilatörler, epinefrin ve steroidlerin kullanımı konusunda akıl karıştırıcı sonuçlar ve yaklaşımlar mevcuttur. Ülkemizde de tedavisi konusunda tam bir uzlaşma sağlanamamıştır. Bu yazıda, akut bronşiyolitte tedavi yaklaşımları son çalışmaların ışığında gözden geçirilmiştir.

Current treatment of acute bronchiolitis

The most common lower repiratory tract infection in infants younger than two years is acute viral bronchiolitis that is leading cause of hospitalisation under six months of age. Little worldwide consensus exists about the best management strategies for this common disease are caring airway, maintenance of adequate hydration and oxygenation. Managements and the results in the use of bronchodilators, epinephrine and corticosteroids for bronchiolitis are conflicting. There is considerable controversy regarding ıts management in our country too. Here we review the treatment of acute bronchiolitis with the guidance of the recent literature.

PDF

___

1. Goodmann D. Bronchiolitis. In: Behrman RE, Kleigman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17th ed. Pennyslyvania: Saunders, 2004: 1415-7.
2. Tristram DA, Welliver RC. Bronchiolitis. In: Long SS, Pickering LK, Prober CG (eds). Principles and Practice of Pediatric Infectious Diseases. New York: Churchill Livingstone, 2003: 213-9.
3. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003; 22(Suppl 2): 76-82.
4. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143(Suppl): 127-32.
5. Fitzgerald AD, Kilham HA. Bronchiolitis: Assessment and evidence based management. Med J Aust 2004; 180: 399-404.
6. Mulholland EK, Olinsky A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet 1990; 335: 1259-61.
7. Phelan P, Olinsky A, Robertson C. Clinical Patterns of Acute Respiratory Infections. Oxford: Blackwell Science, 1994: 52-93.
8. Wilson DF, Horn SD, Smout R, Gassaway J, Torres A. Severity assessment in children with bronchiolitis using the pediatric component of the comprehensive severity index. Pediatr Crit Care Med 2000; 1: 190-1.
9. DeNicola LK, Gayle MO. Bronchiolitis. J Pediatr 1993; 122: 145-51.
10. Çokuğraş H, Karadağ B, Dağlı E ve ark. Toraks Derneği akut bronşiyolit tanı ve tedavi rehberi. Toraks Dergisi 2002; 3: 30-5.
11. Bolling C, Farrel M, Reeves S. (Bronchiolitis team members) Evidence based clinical practice guideline for infant with bronchiolitis. Cincinnati Children’s Hospital Medical Center. 2001, Nov (www.cincinnatichildrens. org/health/info/chest/bronchiolitis.htm).
12. Conway E, Schoettker PJ, Rich K, et al. Empowering respiratory therapists to take a more active role in delivering quality care for infants with bronchiolitis. Respir Care 2004; 49: 589-99.
13. Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis: A systematic review. Arch Pediatr Adolesc Med 2004; 158: 119-26.
14. Lozano JM, Wang E. Bronchiolitis. Clin Evid 2002; 8: 291-303.
15. Hodge D, Chetcuti PAJ. RSV: Management of the acute episode. Paed Respir Rev 2002; 1: 215-20.
16. Scarfone RJ. Controversies in the treatment of bronchiolitis. Curr Opin Pediatr 2005; 17: 62-6.
17. King VJ, Viswanathan M, Bordley C, et al. Pharmacologic treatment of bronchiolitis in infants and children. Arch Pediatr Adolesc Med 2004; 158: 127-37.
18. Steiner RW. Treating acute bronchiolitis associated with RSV. Am Fam Physician 2004; 69: 325-30.
19. Bergman AB. Pulse oximetry. Arch Pediatr Adolesc Med 2004; 158: 594-5.
20. Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2004; 158: 527-30.
21. Yasui K, Baba A, Iwasaki Y, et al. Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Pediatr Int 2005; 47: 190-5.
22. Frieri M. Airway epithelial cell release of cytokines: Modulation by various therapeutic agents. Allergy Asthma Proc 2004; 25: 387-93.
23. Mallory GB, Motoyama EK, Koumbourlis AC, et al. Bronchial reactivity in infants in acute respiratory failure with viral bronchiolitis. Pediatr Pulmonol 1989; 6: 253-9.
24. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilator therapy in bronchiolitis (Cochrane Review). The Cochrane Library 2002; 3.
25. Flores G, Horwitz RI. Efficacy of b2 agonists in bronchiolitis: A reappraisal and meta-analysis. Pediatrics 1997; 100: 233-9.
26. Menon K, Stutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995; 126: 1004-7.
27. Betrand P, Arabinar H, Castro E, et al. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001; 31: 284-8.
28. Hartling L, Wiebe N, Russell K, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med 2003; 157: 957-64.
29. Ray MS, Singh V. Comparison of nebulized adrenaline versus salbutamol in wheeze associated respiratory tract infections in infants. Indian Pediatr 2002; 39: 12-22.
30. Mull CC, Scarfone RJ, Ferri LR, et al. A randomized trial of nebulized epinephrine vs. albuterol in the ED treatment of bronchiolitis. Arch Pediatr Adolesc Med 2004; 158: 113-8.
31. Hariprakash S, Alexander J, Carroll W, et al. Randomized controlled trial of nebulized adrenaline in acute bronchiolitis. Pediatr Allergy Immunol 2003; 14: 134-9.
32. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349: 27-35.
33. Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89: 302-6.
34. Nutman J, Brooks LJ, Deakins KM, et al. Racemic versus L-epinephrine aerosol in the treatment of postextubation laryngeal edema: Results from a prospective, randomized, double-blind study. Crit Care Med 1994; 22: 1591-4.
35. Wright RB, Pomerantz WJ, Luria JW. New approaches to respiratory infections in children. Bronchiolitis and croup. Emerg Med Clin North Am 2002; 20: 93-114.
36. Everart ML, Bara A, Kurian M, et al. Anti-colinergic drugs for wheeze in children under the ages of two years. Cochrane Database Syst Rev 2005; 20: CD001279.
37. Kiper N. Akut bronşiyolitte tedavi. Astım Allerji İmmünoloji 2004; 2: 54-5.
38. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004; (3): CD004878.
39. Cade A, Brownlee KG, Conway SP, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82: 126-30.
40. Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: A prospective, double-blind, randomized trial. Crit Care Med 1994; 22: 566-72.
41. Friis B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomized study. Arch Dis Child 1984; 59: 1038-45.
42. Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med 2002; 156: 322-4.
43. Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J 1998; 17: 231-6.